Work

Abstract B022: Diversity of enrollment in prostate cancer clinical trials: Current status and future directions

Year: 2020

Type: conference-abstract

Source: Cancer Epidemiology Biomarkers & Prevention

DOI: 10.1158/1538-7755.disp18-b022

Authors: Emily Rencsok, Latifa Bazzi, Rana McKay, Franklin Huang, Adam Friedant, Jake Vinson, Jelani Zarif, Stacey Simmons, Paul Villanti, Philip Kantoff, Elisabeth Heath, Daniel George, Lorelei Mucci

Institutions: Harvard University, University of Michigan, University of California San Diego, Moores Cancer Center, Dana-Farber Cancer Institute, Prostate Cancer Clinical Trials Consortium, Johns Hopkins University, Bayer (United States), Movember Foundation, Memorial Sloan Kettering Cancer Center, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Duke Cancer Institute

Language: English

Topic: Ethics in Clinical Research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

OpenAlex ID: W3048947072

Cites:

Cited by:

Related to: 10